Türkçe içerikler

Türkçe okuyabileceğiniz rehberler:

Beijing · China

Peking University People’s Hospital

Haematological malignancy and stem cell transplantation expertise through the Peking University Institute of Hematology.

Blood cancers

Information reviewed

Peking University People’s Hospital

01

A closer look at the hospital

Peking University People’s Hospital is a major teaching hospital with particular strength in haematology and stem-cell transplantation. The Peking University Institute of Hematology connects clinical care and research in blood cancers, transplantation and treatment-related problems. Families comparing transplant options can use a consultation to examine donor choice, complications and longer-term care.

Published work includes haploidentical stem-cell transplantation, immune recovery after transplant, infection and relapse. A useful assessment goes beyond whether transplantation is possible: disease control beforehand, general health, available donors and monitoring after returning home all need consideration.

Transplantation is a continuous course of care, with donor selection only one part. The haematology programme also studies disease before transplant and immune recovery, infection and relapse afterwards. This wider perspective matters for families coordinating caregivers, donors and continuing treatment across countries.

02

Clinical strengths

Allogeneic stem-cell transplantation

Allogeneic stem-cell transplantation is a defining field of the hospital’s haematology programme, with haploidentical transplantation a longstanding research focus. Preparation involves the patient, donor and clinical team, bringing disease control, typing, organ function and infection into assessment.

Care continues after treatment through engraftment and immune monitoring, complication management and disease surveillance. An international transplant plan therefore includes observation near the hospital and specialist follow-up at home as well as admission.

Leukaemia and blood cancer assessment

The decision to proceed to transplant or other intensive treatment depends on disease classification, response and current status. Complete marrow, molecular and residual disease records support discussion of the treatment goal and sequence.

Care after transplantation

Post-transplant care addresses infection, immune recovery, graft-versus-host disease and relapse. International patients should discuss follow-up near the hospital, readiness for travel, handover to local clinicians and contact arrangements for problems.

03

Specialists & clinical teams

Xiaojun Huang

Haematology and stem-cell transplantation

A member of the Chinese Academy of Engineering whose institutional profile covers haematology and transplantation. The programme’s research is relevant to donor selection, transplant strategies and care afterwards.

View supporting source

Peking University Institute of Hematology team

Transplantation, immune recovery and complications

Published institute work addresses infection, immune recovery and relapse after transplantation. Referral should be matched to the disease, any previous transplant and the current clinical problem.

View supporting source

Study results describe selected patient groups, not an individual doctor’s success rate. Availability, case acceptance and the treating team require hospital confirmation.

04

Your international care journey

For transplant enquiries, prepare patient and potential donor information without assuming a relative will be suitable. Obtain the hospital’s acceptance and assessment requirements before arranging testing, caregivers and an extended stay. Discuss continuing haematology care at home in advance.

  1. Share your records and questions

    Send the diagnosis, pathology, imaging and treatment history. Explain whether you want a second opinion, information about a treatment or an in-person visit. We help organise the records and identify missing information.

  2. Confirm the specialty and acceptance

    The relevant service confirms whether it can accept the case and whether pathology review or more records are needed. The hospital determines whether remote assessment or a multidisciplinary opinion is appropriate.

  3. Agree appointments, costs and travel

    Confirm the campus, first appointment, proposed assessment and payment requirements before arranging visas, accommodation, transport and interpreting. Discuss caregivers and length of stay when repeated treatment is expected.

  4. Attend assessment and discuss the plan

    The clinicians assess the case, arrange necessary tests and explain suitable options, expected benefits and risks. Discuss costs and logistics alongside the clinical plan before deciding on the next step.

  5. Stay informed during treatment

    Agreed support can include appointments, interpreting and communication during care. Keep track of questions and clinical feedback, and review schedules, costs and family arrangements if the treatment plan changes.

  6. Return home with a follow-up plan

    Before departure, collect the discharge summary, pathology and imaging, medicines and follow-up plan. Clarify pending reports and contact arrangements, with support for communication between local and treating clinicians where agreed.

What to prepare for the first enquiry

Prepare marrow and molecular reports, residual disease assessments, prior transplant or cellular therapy details and any HLA typing already completed.

Diagnosis & pathology

Diagnosis summary, complete pathology, immunohistochemistry, available molecular tests and where tissue is held.

Original imaging

Recent and pretreatment imaging studies with reports and dates, so changes can be compared.

Treatment timeline

Operations, radiotherapy plans, each drug regimen, responses and major side effects; current medicines and allergies.

Your practical needs

Home country, preferred language, possible travel dates, caregiver needs and the questions you want answered.

Start with the records you already have. We can help identify gaps; do not arrange additional tests solely to make an enquiry.

See the full records checklist

Practical details to settle before travel

Costs & payment

Ask what the hospital estimate includes, deposits, additional charges and refund arrangements. Plan travel and living costs separately. Insurance coverage and direct billing require confirmation.

Language & records

Confirm interpreting for appointments, communication during treatment and the language of records. Our China coordination includes Chinese and English support; other languages need advance confirmation of availability and arrangements.

Campus, accommodation & caregivers

Consultations, tests and admission may take place at different sites. Distance, accessibility, caregiver rules and follow-up frequency all affect the itinerary and should be considered once the clinical plan is clearer.

Length of stay & returning home

Assessment, surgery, radiotherapy and cellular treatment have different schedules. Ask the hospital for the expected course, allowing for results and changes in the plan. Confirm readiness to return home with the clinical team.

05

How Chirona can help

From organising records and contacting an appropriate specialty to travel in China and follow-up at home, we help connect the practical steps. Tell us the diagnosis, treatment so far and the question you most want answered.

Make your history easier to review

Organise treatments and key reports, help with necessary translation and bring the important questions to the clinician.

Find the appropriate clinical service

Enquire with the relevant specialty, follow up on record requirements and help clarify acceptance and appointments.

Coordinate the practical steps in China

Within the agreed scope, help with visa documentation, travel, arrival transport, accommodation and accompaniment.

Keep communication connected

Help organise consultation feedback, records for home and follow-up requirements, with continued contact as agreed.

The hospital and clinicians make diagnostic, treatment and acceptance decisions. Chirona provides consultation and care coordination within the agreed scope.

Explore our service process

06

Questions before you decide

Can I enquire without a fully matched related donor?

Yes. Describe any typing already completed and potential donors. The team can assess possible donor pathways alongside the disease and patient’s condition; suitability for a particular approach requires individual review.

Can I request one of the specialists featured here?

Tell us your preference and we can help enquire. The hospital confirms acceptance, the specialist’s involvement and who provides outpatient or inpatient care. It may also recommend another suitable clinician within the specialty.

Can I contact Chirona before choosing a hospital?

Yes. Share the diagnosis, treatment history and the decision you need help with. We can organise the questions to consider when comparing hospitals and explain the coordination available.

Does submitting records confirm treatment?

Submitting records starts the assessment. The hospital must confirm acceptance and clinical suitability and may require more information or in-person tests. Appointment confirmation, the treatment plan and costs should be clarified separately.

Sources & further reading

Profiles draw on the institutional sources below, including historical material where it explains a programme’s development. Appointments, services and research recruitment can change and need confirmation when enquiring.

  1. Peking University People’s Hospital: haematology
  2. Xiaojun Huang
  3. Peking University Institute of Hematology team
  4. Clinical programmes & patient services · english.pkuph.cn

Make the next conversation count.

Share your diagnosis and the question you want to resolve. We can help organise your records and clarify the next steps for a professional review.

Request a case review

New inquiry

Chirona Assistant

What would you like to understand?

Explore your questions about cancer care. We can organize what you know and help you prepare for professional review.